Sanofi: finalises acquisition of Translate Bio
(CercleFinance.com) - Sanofi announced today that it has finalised the acquisition of Translate Bio.
This transaction should allow initiatives to be accelerated for the development of vaccines and therapeutic agents, based on mRNA technology.
This acquisition will in particular allow Sanofi to provide a valuable asset to its Centre of Excellence dedicated to mRNA vaccines and to apply it to other strategic areas such as immunology, oncology and rare diseases.
Copyright (c) 2021 CercleFinance.com. All rights reserved.